Medicare’s spending on ‘ultra-expensive’ drugs increased by 1,170% in 6 years Katie Adams – 19 hours ago Print | Email

(By Katie Adams for Becker’s Hospital Review)

As more drugs enter the market with five-figure annual list prices, a large share of Medicare’s drug spending is going toward these “ultra-expensive” treatments, according to research published June 7 in Health Affairs.  Continue reading the article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org